83 related articles for article (PubMed ID: 26136390)
1. Hepatitis C Management and the Infectious Diseases Pharmacist.
Wenzler E; Dickson W; Vibhakar S; Adeyemi OM; Danziger LH
Clin Infect Dis; 2015 Oct; 61(7):1201-2. PubMed ID: 26136390
[No Abstract] [Full Text] [Related]
2. Provision of clinical pharmacist services for individuals with chronic hepatitis C viral infection: Joint Opinion of the GI/Liver/Nutrition and Infectious Diseases Practice and Research Networks of the American College of Clinical Pharmacy.
Mohammad RA; Bulloch MN; Chan J; Deming P; Love B; Smith L; Dong BJ; GI Liver Nutrition and Infectious Diseases Practice and Research Networks of the American College of Clinical Pharmacy
Pharmacotherapy; 2014 Dec; 34(12):1341-54. PubMed ID: 25359244
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C Management and the Infectious Diseases Physician: A Survey of Current and Anticipated Practice Patterns.
Chastain CA; Beekmann SE; Wallender EK; Hulgan T; Stapleton JT; Polgreen PM
Clin Infect Dis; 2015 Sep; 61(5):792-4. PubMed ID: 25979310
[TBL] [Abstract][Full Text] [Related]
4. Consumer, physician, and payer perspectives on primary care medication management services with a shared resource pharmacists network.
Smith M; Cannon-Breland ML; Spiggle S
Res Social Adm Pharm; 2014; 10(3):539-53. PubMed ID: 24055137
[TBL] [Abstract][Full Text] [Related]
5. Pharmacist integration into the medical home: qualitative analysis.
Kozminski M; Busby R; McGivney MS; Klatt PM; Hackett SR; Merenstein JH
J Am Pharm Assoc (2003); 2011; 51(2):173-83. PubMed ID: 21382807
[TBL] [Abstract][Full Text] [Related]
6. Reflections on the evolving role of Infection Services in New Zealand.
Arnold BJ; Blackmore TK
N Z Med J; 2015 Mar; 128(1410):9-12. PubMed ID: 25829033
[No Abstract] [Full Text] [Related]
7. Implementation of a pharmacist-led antimicrobial management team in a community teaching hospital: use of pharmacy residents and pharmacy students in a prospective audit and feedback approach.
Laible BR; Nazir J; Assimacopoulos AP; Schut J
J Pharm Pract; 2010 Dec; 23(6):531-5. PubMed ID: 21507858
[TBL] [Abstract][Full Text] [Related]
8. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units.
Kucukarslan SN; Peters M; Mlynarek M; Nafziger DA
Arch Intern Med; 2003 Sep; 163(17):2014-8. PubMed ID: 14504113
[TBL] [Abstract][Full Text] [Related]
9. Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT).
Hazen AC; Sloeserwij VM; Zwart DL; de Bont AA; Bouvy ML; de Gier JJ; de Wit NJ; Leendertse AJ
BMC Fam Pract; 2015 Jul; 16():76. PubMed ID: 26135582
[TBL] [Abstract][Full Text] [Related]
10. [Physicians referent for antimicrobial therapy. Results of a survey conducted during a French Infectious Diseases Society meeting].
Alfandari S; Riche A; Rabaud C; Cremieux AC; Gauzit R; Roblot F
Med Mal Infect; 2010 Oct; 40(10):582-5. PubMed ID: 20889273
[TBL] [Abstract][Full Text] [Related]
11. Interdisciplinary patient care in the intensive care unit: focus on the pharmacist.
Erstad BL; Haas CE; O'Keeffe T; Hokula CA; Parrinello K; Theodorou AA
Pharmacotherapy; 2011 Feb; 31(2):128-37. PubMed ID: 21275491
[TBL] [Abstract][Full Text] [Related]
12. The clinical pharmacist as a member of the burn team.
Anderson PO; Wachtel TL; Frank HA; Trubo BG
Contemp Pharm Pract; 1982; 5(2):120-3. PubMed ID: 10256910
[TBL] [Abstract][Full Text] [Related]
13. Perceptions of pharmacists' integration into patient-centered medical home teams.
Patterson BJ; Solimeo SL; Stewart KR; Rosenthal GE; Kaboli PJ; Lund BC
Res Social Adm Pharm; 2015; 11(1):85-95. PubMed ID: 24954185
[TBL] [Abstract][Full Text] [Related]
14. Integration of a primary healthcare pharmacist.
Kolodziejak L; Rémillard A; Neubauer S
J Interprof Care; 2010 May; 24(3):274-84. PubMed ID: 20388026
[TBL] [Abstract][Full Text] [Related]
15. Why should infectious disease physicians care for the hepatitis C-infected patient?
Godofsky E
Infect Dis Clin North Am; 2012 Dec; 26(4):839-47. PubMed ID: 23083818
[TBL] [Abstract][Full Text] [Related]
16. Collaborative practice model between cardiologists and clinical pharmacists for management of patients with cardiovascular disease in an outpatient clinic.
Ripley TL; Adamson PB; Hennebry TA; Van Tuyl JS; Harrison DL; Rathbun RC
Ann Pharmacother; 2014 Mar; 48(3):412-9. PubMed ID: 24321852
[TBL] [Abstract][Full Text] [Related]
17. A national survey of hospice administrator and pharmacist perspectives on pharmacist services and the impact on medication requirements and cost.
Latuga NM; Wahler RG; Monte SV
Am J Hosp Palliat Care; 2012 Nov; 29(7):546-54. PubMed ID: 22218918
[TBL] [Abstract][Full Text] [Related]
18. Care of the patient with hepatitis C virus infection. Preface.
McGovern BH
Infect Dis Clin North Am; 2012 Dec; 26(4):xi-xii. PubMed ID: 23083830
[No Abstract] [Full Text] [Related]
19. Role of a pharmacist in improving rational drug therapy as part of the patient care team.
Smith WE
Ann Pharmacother; 2007 Feb; 41(2):330-5. PubMed ID: 17299008
[TBL] [Abstract][Full Text] [Related]
20. Treatment options for patients with hepatitis C: role of pharmacists in optimizing treatment response and managing adverse events.
Smith JP
Pharmacotherapy; 2008 Sep; 28(9):1151-61. PubMed ID: 18752386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
